[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients
BJU International, 04/24/2012Poulsen MH et al.
Due to a relatively low sensitivity and a correspondingly rather low positive predictive values (PPV), fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) is not ideal for primary lymph node staging in patients with prostate cancer. However, FCH PET/CT does convey important additional information otherwise not recognised, especially for bone metastases.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.